Fishers, IN, United States of America

Jianliang Lu

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Spotlight on Inventor Jianliang Lu

Introduction:

Jianliang Lu is a prolific inventor based in Fishers, IN, US, with a remarkable portfolio of 14 patents to his name. His innovative spirit and impactful contributions in the field of pharmaceuticals have solidified his reputation as a visionary inventor.

Latest Patents:

Among his latest patents is the groundbreaking invention of "Inhibitors of Diacylglycerol Acyltransferase," which presents compounds of formula I that hold significant potential in the realm of pharmaceutical research. Additionally, Jianliang Lu has made strides with "MCH Receptor Antagonists," unveiling a novel compound that shows promise in combating obesity and related ailments.

Career Highlights:

Currently affiliated with Eli Lilly and Company, Jianliang Lu has seamlessly integrated his innovative prowess with the cutting-edge research environment at the company. His dedication to pushing the boundaries of pharmaceutical innovation is evident in both his patent portfolio and career trajectory.

Collaborations:

Within Eli Lilly and Company, Jianliang Lu has collaborated with esteemed colleagues such as Sunil Nagpal and Ying Kwong Yee. Their collective efforts have resulted in the development of pioneering solutions that strive to address critical healthcare challenges.

Conclusion:

In conclusion, Jianliang Lu stands as a beacon of ingenuity in the realm of pharmaceutical inventions. His relentless pursuit of innovation, coupled with his strategic collaborations, underscores his commitment to advancing healthcare solutions. Jianliang Lu's patent portfolio serves as a testament to his unwavering dedication to pioneering novel treatments that have the potential to transform lives globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…